Sven Arne Andréasson
Direttore/Membro del Consiglio presso MENDUS AB
Patrimonio netto: - $ in data 31/05/2024
Profilo
Sven Arne Andréasson is currently the Chairman at Operations Leadership Oil AB and the Vice Chairman at Cellastra, Inc. He is also an Independent Director at Mendus AB and a Director at Galenos SRL.
Additionally, he serves as the Deputy Director at Stefan Forsberg Consulting AB.
In his former positions, Mr. Andréasson was the Co-Chief Executive Officer at Active Biotech AB from 1999 to 2008.
He also served as the Chief Executive Officer at Novavax AB from 2012 to 2013 and at Beta-Cell NV from 2008 to 2012.
Furthermore, he held the position of President & Vice President at Pharmacia AB from 1976 to 1999 and President at Pharmacia SAS from 1994 to 1999.
Mr. Andréasson's education includes an undergraduate degree from Stockholm School of Economics.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 31/12/2022 | 0 ( -.--% ) | - $ | 31/05/2024 |
Posizioni attive di Sven Arne Andréasson
| Società | Posizione | Inizio |
|---|---|---|
| MENDUS AB | Direttore/Membro del Consiglio | 01/01/2020 |
| Stefan Forsberg Consulting AB | Corporate Officer/Principal | - |
| Galenos SRL | Direttore/Membro del Consiglio | 01/01/2014 |
Cellastra, Inc.
 Cellastra, Inc. BiotechnologyHealth Technology The American company was founded by Karl L. Mettinger and Kent Persson, with Karl L. Mettinger serving as CEO since incorporation. | Direttore/Membro del Consiglio | - |
| Operations Leadership Oil AB | Presidente | 15/10/2010 |
Precedenti posizioni note di Sven Arne Andréasson
| Società | Posizione | Fine |
|---|---|---|
ERYTech Pharma SA
 ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. | Direttore/Membro del Consiglio | 23/06/2023 |
| NOVAVAX, INC. | Corporate Officer/Principal | 01/05/2023 |
| MENDUS AB | Direttore/Membro del Consiglio | 26/05/2016 |
Novavax AB
 Novavax AB Pharmaceuticals: GenericHealth Technology Novavax AB is engaged in research and development of vaccines. Its products include Matrix and AbiSCO. The company was founded by Bror Morein in 1999 and is headquartered in Uppsala, Sweden. | Amministratore Delegato | 01/11/2013 |
| ░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Sven Arne Andréasson
| Stockholm School of Economics | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| ACTIVE BIOTECH AB | Health Technology |
| CANTARGIA AB | Health Technology |
| NOVAVAX, INC. | Health Technology |
| MENDUS AB | Health Technology |
| Aziende private | 19 |
|---|---|
TiGenix NV
 TiGenix NV Medical SpecialtiesHealth Technology TiGenix NV engages in the research, development, and commercialization of biopharmaceutical products. The firm's portfolio includes allogeneic adipose-derived stem cells and allogeneic cardiac stem cells. It intends to treat Crohn's disease, sepsis, autoimmune disorders, acute myocardial infarction, and chronic cardiovascular indication. The company was founded by Gil Beyen and Frank P. Luyten on February 21, 2000 and is headquartered in Leuven, Belgium. | Health Technology |
Beta-Cell NV
 Beta-Cell NV Miscellaneous Commercial ServicesCommercial Services Beta-Cell NV is a Belgian company that offers a cell replacement therapy for diabetes. The private company is based in Brussels, Belgium. The company's therapy provides a cure for diabetes, which affects people of all ages, genders, and ethnicities. | Commercial Services |
Unibioscreen SA
 Unibioscreen SA Pharmaceuticals: MajorHealth Technology Unibioscreen is a privately held specialist oncology discovery & development company. Founded in 1999 and based in Brussels, Belgium. Unibioscreen has successfully discovered, patented and developed 2 novel, first-in-class anti-cancer drug candidates (chemotherapeutics) now in clinical phase I in cancer patients and has also a discovery pipeline. | Health Technology |
| Operations Leadership Oil AB | |
| Pharmacia AB | Health Technology |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Commercial Services |
Novavax AB
Novavax AB Pharmaceuticals: GenericHealth Technology Novavax AB is engaged in research and development of vaccines. Its products include Matrix and AbiSCO. The company was founded by Bror Morein in 1999 and is headquartered in Uppsala, Sweden. | Health Technology |
ERYTech Pharma SA
ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. | Health Technology |
Sista versen 26366 AB
 Sista versen 26366 AB Pharmaceuticals: MajorHealth Technology Sista Versen 26366 AB discovers treatments for inflammatory disorders. Their treatment is based on properties of new classes of endogenous host defense peptides from proteins within the coagulation cascade, which display potent immune-modulating properties. The firm develops drugs that prevent sepsis development. The company was founded by Artur Schmidtchen and Nils Martin Malmsten on October 26, 2009 and is headquartered in Lund, Sweden. | Health Technology |
Cellastra, Inc.
Cellastra, Inc. BiotechnologyHealth Technology The American company was founded by Karl L. Mettinger and Kent Persson, with Karl L. Mettinger serving as CEO since incorporation. | Health Technology |
| Galenos SRL | |
| Kabivitrum AB | |
| Stefan Forsberg Consulting AB | |
| Advet AB | |
| Advet Production AB | |
| Pharmacia SAS | |
| Kabi Pharmacia | |
Pharmacia Arzneimittel GmbH
 Pharmacia Arzneimittel GmbH Pharmaceuticals: MajorHealth Technology Pharmacia Arzneimittel GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Ratingen, Germany. | Health Technology |
Kabipharmacia International
 Kabipharmacia International Pharmaceuticals: MajorHealth Technology Kabipharmacia International is a French company that manufactures pharmaceutical products. | Health Technology |
- Borsa valori
- Insiders
- Sven Arne Andréasson
